Supreme Court Refuses To Review Pemetrexed Case

Alimta Litigation Revolved Around Doctrine Of Equivalents

The US Supreme Court has refused a certiorari petition to review a decision involving Dr Reddy’s and Pfizer over Eli Lilly’s Alimta that revolved around the doctrine of equivalents.

No_Law_Gavel
The Supreme Court will not review the litigation • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin